Premium
Replimune Group Inc (REPL)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex v... Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.78 | -6.3829787234 | 12.22 | 12.54 | 10.68 | 571495 | 11.56646678 | CS |
| 4 | -1.29 | -10.1335428123 | 12.73 | 14.7952 | 10.68 | 619603 | 12.93598627 | CS |
| 12 | -0.15 | -1.29421915444 | 11.59 | 14.7952 | 10 | 723398 | 12.56988195 | CS |
| 26 | 1.06 | 10.2119460501 | 10.38 | 16.52 | 9.94 | 770196 | 12.39391343 | CS |
| 52 | 2.55 | 28.6839145107 | 8.89 | 16.52 | 4.92 | 880490 | 9.9966425 | CS |
| 156 | -4.81 | -29.6 | 16.25 | 29.5229 | 4.92 | 754792 | 12.96223982 | CS |
| 260 | 0.25 | 2.23413762288 | 11.19 | 54.85 | 4.92 | 581687 | 17.52132411 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
